We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Long-Term Benefit of Knee Arthroplasty in Arthritis Patients

By HospiMedica staff writers
Posted on 22 Aug 2001
A 10-year follow-up study of posterior cruciate ligament-retaining total knee arthroplasty has found the procedure an excellent treatment option for rheumatoid arthritis patients.
Conducted by researchers from the department of orthopedic surgery, Rush-Presbyterian-St. More...
Luke's Medical Center (Chicago, IL, USA), the study was published in The Journal of Bone and Joint Surgery (2001,83:1231-1236).

The research was prompted by recent reports of a high rate of later instability requiring revision in patients who had undergone the procedure. The prospective study involved 72 procedures performed on 51 patients with rheumatoid arthritis. All of the procedures were performed with the Miller-Galante I prosthesis. Deaths before follow-up reduced the number studied to 46 knees (32 patients). The researchers evaluated these clinically, with special attention to posterior instability, and radiographically at yearly intervals for a mean period of 10.5 years (range of 8-14 years).

The results showed a good or excellent result for 44 of 46 knees, although nine of the original 72 knees had revision of the implant, with six of the revisions due to failure of a patellar component. At 10 years, the rate of survival was 93% with tibial or femoral revision as the end point, and 81% with any re-operation as the end point. The researchers found no aseptic loosening and identified posterior instability in only two (2.8%, both in the same patient) of the original 72 knees.




Related Links:
Journal of Bone and Joint Surgery

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.